Skip to content
lsd.com

Indication

Mild Cognitive Impairment

3 registered trials testing Psilocybin, Ketamine, DMT for this indication, 1 recruiting now.

3
Registered trials
1
Recruiting
0
In Phase 3

Substances tested

Being studied with

Stay told

When a new trial opens

Research alerts

Get a notification when a trial for Mild Cognitive Impairment trials starts recruiting

This registry is rebuilt every day. If no trial is recruiting for you today, that can change within weeks.

This form sends your email address and the topic of this page to Brevo, our email provider, which stores them on servers in the European Union. We never sell that address, never share it with anyone, and never use it for advertising. One email deletes it. What is held, and where.

Trials

All 3 trials for Mild Cognitive Impairment

TrialStatusPhaseSubstanceSites
Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's DiseaseNCT04123314 · Johns Hopkins UniversityRecruitingEarly Phase 1psilocybin1
Efficacy of Sublingual 5-MeO-DMT for Reducing Anxiety and Depression in MCINCT06812221 · Biomind Labs Inc.CompletedPhase 1 / Phase 2dmt1
Single-dose Ketamine Treatment to Improve Depression in Mild Cognitive ImpairmentNCT06069843 · Icahn School of Medicine at Mount SinaiActive, not recruitingPhase 2ketamine1

Records from ClinicalTrials.gov API v2, data build 2026-08-25. Indications are the sponsors’ own words. LSD.com reports registered clinical research. It is not medical advice, it is not a recommendation to take any substance, and trial listings are not endorsements. Talk to a clinician.